HER-2/NEU AMPLIFICATION IN FINE NEEDLE ASPIRATES FROM PRIMARY BREAST CANCER: IS IT A PREDICTIVE MARKER IN PATIENTS TREATED WITH NEO-ADJUVANT ANTHRACYCLINE-BASED CHEMOTHERAPY?

被引：0
|
作者：
Bozzetti, Cecilia [1 ]
Musolino, Antonino [1 ]
Personeni, Nicola [1 ]
Nizzoli, Rita [1 ]
Michiara, Maria [1 ]
Di Blasio, Beatrice [1 ]
Ceci, Guido [1 ]
Camisa, Roberta [1 ]
Cascinu, Stefano [2 ]
Ardizzoni, Andrea [1 ]
机构：
[1] Univ Hosp, Med Oncol Unit, Parma, Italy
[2] Le Torrette Hosp, Med Oncol Unit, Ancona, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [1] Correlation between HER-2/neu amplification in fine needle aspirates from breast carcinoma and responses to neoadjuvant anthracycline-based chemotherapy
    Bozzetti, Cecilia
    Musolino, Antonino
    Personeni, Nicola
    Nizzoli, Rita
    Martella, Eugenia
    Lagrasta, Costanza
    Leonardi, Francesco
    Michiara, Maria
    Camisa, Roberta
    Ardizzoni, Andrea
    ANNALS OF ONCOLOGY, 2004, 15 : 16 - 16
  • [2] HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer
    Bozzetti, C
    Nizzoli, R
    Guazzi, A
    Flora, M
    Bassano, C
    Crafa, P
    Naldi, N
    Cascinu, S
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1398 - 1403
  • [3] HER-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a Mexican population of locally advanced breast cancer patients
    Muñoz-Gonzalez, D
    Zeichner-Gancz, I
    Candelaria, M
    Ramirez-Ugalde, MT
    Perez-Sanchez, M
    Cervantes-Vazquez, G
    Cantu-de Leon, D
    Mora-Tizcareño, A
    Leonor-Ortíz, J
    MEDICAL ONCOLOGY, 2005, 22 (01) : 23 - 28
  • [4] HER-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a Mexican Population of locally advanced breast cancer patients
    David Muñoz-Gonzalez
    Isabel Zeichner-Gancz
    Myrna Candelaria
    Maria Teresa Ramirez-Ugalde
    Manuel Perez-Sanchez
    Guadalupe Cervantes-Vazquez
    David Cantu-de Leon
    Arcelia Mora-Tizcareño
    Julio Leonor-Ortíz
    Medical Oncology, 2005, 22 : 23 - 28
  • [5] Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas
    Nizzoli, R
    Bozzetti, C
    Crafa, P
    Naldi, N
    Guazzi, A
    Di Blasio, B
    Camisa, R
    Cascinu, S
    DIAGNOSTIC CYTOPATHOLOGY, 2003, 28 (03) : 142 - 146
  • [6] The Predictive Value of Serum Serum Her-2/neu for Response to Anthracycline-Based and Trastuzumab-Based Neoadjuvant Chemotherapy of Advanced Primary Breast Cancer
    Jeon, C.
    Lee, J. S.
    Min, W.
    CANCER RESEARCH, 2010, 70
  • [7] The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer
    Schippinger, Walter
    Dandachi, Nadia
    Regitnig, Peter
    Hofmann, Gunter
    Balic, Marija
    Neumann, Rainer
    Samonigg, Hellmut
    Bauernhofer, Thomas
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (04) : 630 - 637
  • [8] Her-2/neu as predictive marker for endocrine therapy and chemotherapy in patients with metastatic breast cancer
    Köstler, WJ
    Zielinski, CC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 : S73 - S84
  • [9] Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer
    Wolfgang J. Köstler
    Christoph C. Zielinski
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 73 - 84
  • [10] TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Zhang, Pin
    Li, Qing
    Ma, Fei
    Fan, Ying
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 531 - 537
12345